Indian Army Department Of Military Affairs Medicines Tender 2025 Eye Drops Tablets Vaccine 49998

To bid in this Army procurement, bidders must submit PAN, GSTIN, cancelled cheque, EFT mandate, and OEM authorization if required. Ensure products meet the 2-year shelf life with expiry before Dec 2027 and be prepared for 50% quantity adjustments during contract. Complete documentation is essential.

Required documents include PAN, GSTIN, cancelled cheque, EFT mandate, and OEM authorization where applicable. Bidders must provide product certificates, manufacturer authority, and evidence of shelf-life compliance for each item listed in the 9-item BOQ.

All items must have a minimum 2 years shelf life at delivery, with the delivered stock having at least 6 months of remaining life before expiry. Expiry management requires replacement before the six-month window.

The purchaser may modify quantity up to 50% of bid quantity at contract placement and again during currency, with delivery timelines adjusted proportionally and subject to a minimum of 30 days.

The BOQ covers nine items: eye drops, hydroxychloroquine 200mg, etoricoxib 90mg, linagliptin 5mg, glucosamine 250mg with chondroitin 200mg, diclofenac/paracetamol/serratiopeptidase, salbutamol 4mg, omega fatty acids with antioxidants, and influenza vaccine.

Deliveries must ensure expiry not less than six months from the date of delivery. If stock approaches expiry, replacement must occur; items must be replaced if shelf life shortens below the required threshold.

If bidding via an authorized distributor, submit OEM authorization with provider details: name, designation, address, email, and phone. This confirms supply rights for the specified medicines and vaccines under the tender.